Physician profile
Suneetha Budampati
NPI 1285668491
$10,078.67
in general payments reported to CMS, 2019-2025
52 companies · $1,125 in 2025
The $1,125 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,866 · 2020: $825 · 2021: $909 · 2022: $2,154 · 2023: $1,140 · 2024: $1,060 · 2025: $1,125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,325.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,020.47 | 2019-2025 | Proclaim, Eterna |
| Nalu Medical, INC. | $1,177.18 | 2021-2023 | Nalu Neurostimulation System |
| Abbvie INC. | $868.03 | 2022-2025 | Ubrelvy, Botox, Qulipta |
| Collegium Pharmaceutical, INC. | $613.39 | 2019-2025 | Xtampza, Belbuca |
| Medtronic USA, INC. | $498.02 | 2019-2020 | |
| Boston Scientific Corporation | $445.85 | 2019-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System |
| Vertos Medical, INC. | $408.80 | 2021-2024 | Mild Device Kit |
| Allergan, INC. | $393.59 | 2019-2022 | |
| Lundbeck LLC | $326.68 | 2022-2024 | Vyepti |
| Mml US, INC. | $266.17 | 2024 | Reactiv8 |
| Spinal Simplicity, LLC | $239.94 | 2022-2025 | Ha Minuteman G3-R |
| Medtronic, INC. | $215.86 | 2021-2025 | Kyphon Express II Kyphopak Tray, Inceptiv |
| Nevro Corp. | $213.85 | 2019-2024 | Senza |
| Ferring Pharmaceuticals INC. | $202.68 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $184.90 | 2019-2023 | Ztlido |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suneetha Budampati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.